Synergistic Bronchial Isolation System with AI, IoT, and Blockchain Integration
Legal Citation
Summary of the Inventive Concept
A novel system integrating a high-resistance implanted bronchial isolation device with AI, IoT, and blockchain technologies to optimize lung disease treatment through personalized airflow dynamics, secure data storage, and real-time monitoring.
Background and Problem Solved
The original patent described a flow control device for treating lung diseases, but it lacked the ability to adapt to individual patient needs and lacked secure data storage. The new inventive concept addresses these limitations by integrating AI, IoT, and blockchain technologies to provide personalized treatment and secure data management.
Detailed Description of the Inventive Concept
The synergistic system consists of a flow control device configured to transition between a closed and open configuration, a machine learning module predicting optimal airflow dynamics for the targeted lung region based on patient-specific data, a blockchain-based secure data storage system tracking and storing patient data, and an IoT-enabled respiratory monitoring device providing real-time feedback. The AI module analyzes patient data and optimizes treatment protocols, while the IoT device tracks patient respiratory patterns and provides real-time feedback to the flow control device.
Novelty and Inventive Step
The new inventive concept is novel and non-obvious in its integration of AI, IoT, and blockchain technologies with the original flow control device, providing a synergistic system that adapts to individual patient needs and ensures secure data management.
Alternative Embodiments and Variations
Alternative embodiments may include varying the AI algorithm, using different IoT devices, or incorporating additional technologies such as robotics or virtual reality. Variations may include using the system for treating other respiratory diseases or integrating with other medical devices.
Potential Commercial Applications and Market
The synergistic bronchial isolation system has significant commercial potential in the medical device industry, particularly in the treatment of lung diseases such as COPD. The system's ability to provide personalized treatment and secure data management makes it an attractive solution for healthcare providers and patients alike.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/04 |
| A | A61 | A61M16/209 |
| A | A61 | A61F2002/043 |
| A | A61 | A61M2205/04 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering focused on respiratory intervention technologies, specifically bronchial isolation and flow control devices for treating pulmonary diseases, requiring expertise in mechanical design, biomedical engineering, and minimally invasive medical technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 3-5 years experience in respiratory medical technologies, familiar with implantable valve mechanisms, digital health monitoring systems, and adaptive medical device design
Obviousness Rationale
A PHOSITA would recognize that integrating digital monitoring and adaptive technologies with existing bronchial isolation devices represents a predictable technological evolution. The source patent's flow control mechanism provides a foundational platform for incorporating intelligent monitoring and personalization technologies. The proposed variations represent logical extensions of existing medical device integration trends, utilizing standard engineering approaches to enhance device functionality and patient outcomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,406 |
|---|---|
| Title | High resistance implanted bronchial isolation devices and methods |
| Assignee(s) | Pulmonx Corporation |